Design and synthesis of novel quinazoline nitrogen mustard derivatives as potential therapeutic agents for cancer

European Journal of Medicinal Chemistry
2013.0

Abstract

Thirteen novel quinazoline nitrogen mustard derivatives were designed, synthesized and evaluated for their anticancer activities in vitro and in vivo. Cytotoxicity assays were carried out in five cancer cell lines (HepG2, SH-SY5Y, DU145, MCF-7 and A549) and one normal human cell line (GES-1), in which compound 22b showed very low IC50 to HepG2 (the IC50 value is 3.06 μM), which was lower than Sorafenib. Compound 22b could inhibit cell cycle at S and G2/M phase and induce cell apoptosis. In the HepG2 xenograft model, 22b exhibited significant cancer growth inhibition with low host toxicity in vivo.

Knowledge Graph

Similar Paper

Design and synthesis of novel quinazoline nitrogen mustard derivatives as potential therapeutic agents for cancer
European Journal of Medicinal Chemistry 2013.0
Design and synthesis of novel pyrazolo[1,5-a]pyrimidine derivatives bearing nitrogen mustard moiety and evaluation of their antitumor activity in vitro and in vivo
European Journal of Medicinal Chemistry 2016.0
Synthesis and biological evaluation of novel 2-(2-arylmethylene)hydrazinyl-4-aminoquinazoline derivatives as potent antitumor agents
European Journal of Medicinal Chemistry 2012.0
Antitumor and antileishmanial evaluation of novel heterocycles derived from quinazoline scaffold: a molecular modeling approach
Medicinal Chemistry Research 2013.0
Design, synthesis, and anti-proliferative evaluation of new quinazolin-4(3H)-ones as potential VEGFR-2 inhibitors
Bioorganic & Medicinal Chemistry 2021.0
Design, synthesis and pharmacological evaluation of new 2-oxo-quinoline derivatives containing α-aminophosphonates as potential antitumor agents
MedChemComm 2017.0
Sulfur and selenium derivatives of quinazoline and pyrido[2,3-d]pyrimidine: Synthesis and study of their potential cytotoxic activity in vitro
European Journal of Medicinal Chemistry 2012.0
Quinoline-azetidinone hybrids: Synthesis and in vitro antiproliferation activity against Hep G2 and Hep 3B human cell lines
Bioorganic & Medicinal Chemistry Letters 2017.0
Quinazoline–tyrphostin as a new class of antitumor agents, molecular properties prediction, synthesis and biological testing
European Journal of Medicinal Chemistry 2012.0
Synthesis of 8-Hydroxyquinoline Derivatives as Novel Antitumor Agents
ACS Medicinal Chemistry Letters 2013.0